The National Pharmaceutical Pricing Authority aims to hold drug manufacturers solely accountable for the excessive pricing of essential med...

Of the total, about 1,282 cases have been registered under Drug (Prices Control) Order 1995, while 184 cases under the DPCO 2013.

The authority has charged Cipla of charging higher prices for a set of drugs than the ceiling price based on a fixed formula.

Of the total 620 medicines under this list, NPPA has fixed the prices of 509 drugs so far, while prices of 102 medicine have not been fixed.

It will enable consumers, who are presently highly dependent on doctors and chemists, to make an informed choice while purchasing medicines.

National Pharma Pricing Authority is studying the judgement and will begin the exercise of calculating the amount overcharged by drug compa...

A drug maker found overcharging will have to shell out the entire sales revenue of the medicine from the date of its launch as penalty, acc...

Drug manufacturing companies such as Cipla, Ranbaxy, Johnson & Johnson and Dr Reddy’s Laboratories (DRL) may have to pay over Rs 2,038 cror...

Allahabad High Court has asked Delhi-based drug firm Modi-Mundipharma to deposit half of the Rs 41 crore it allegedly overcharged consumers...

Drugmakers, such as Dr Reddy’s Laboratories, Wyeth, GlaxoSmithKline (GSK) Pharmaceuticals and Alkem Laboratories, may now have to face stat...

The Supreme Court dismissed a petition by drug major GlaxoSmithKline Pharmaceuticals Ltd (GSK) seeking to restrain the government from taki...

The apex court's decision gives the drug regulator a free hand to recover the amount from the company.

The government has tried to keep the prices of many essential drugs under check through the Drug (Prices Control) Order (DPCO), 1995. The N...

Drug companies including Ranbaxy Laboratories, Dr Reddy’s Laboratories (DRL) and Lupin may have to pay over Rs 1,600 crore as penalties for...

Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has been rendered a mute spectator as drug companies continue to flee...

Pharma majors like Cipla, Ranbaxy and US Vitamin (India) may have to cough up over Rs 1,563 crore for overcharging customers on price-contr...

The government is arming itself with greater powers through a new law to rein in pharma corporations violating price control notifications.